PATENT ESTATE
Focusing fluorescent technology on applications in medicine.
Novel fluorescent tracer agents, transdermal sensor innovations and unique analytical approaches are focused on providing tools to help physicians decrease the burden of chronic diseases.
The MediBeacon intellectual property portfolio includes granted composition of matter, algorithm, and method patents in the US, Europe and globally.
INCREASED BURDEN OF CHRONIC KIDNEY DISEASE
During the 15-year period covered by study, health loss due to kidney disease increased by 18%, while the burden of cardiovascular disease and cancer have decreased by 22% and 13%, respectively.
-JAMA Open Network, Changes in the US Burden of Chronic Kidney Disease From 2002 to 2016, An Analysis of the Global Burden of Disease Study, November 30, 2018